Subject to the completion of the cash acquisition of Pharmasset Inc. (USA, Constituent) by Gilead Sciences Inc. (USA, Constituent), FTSE announces the following changes: | INDEX | CHANGE | EFFECTIVE FROM
START OF TRADING | | FTSE All-World Index | Pharmasset (USA, B17W5V1) will be deleted from the index .
| 18 January 2012 | | FTSE World Index Ex-Multinationals | Pharmasset will be deleted from the index. | 18 January 2012 | | FTSE Global Style Index | Pharmasset will be deleted from the index. | 18 January 2012 |
FREE TRIAL OFFER: FTSE offers free one month index trials to interested clients. For further information or general enquiries please contact us at info@ftse.com or call: | Client Services in UK: | Tel: +44 (0) 20 7866 1810 | | Client Services in Europe, Middle East & Africa: | Tel: +44 (0) 20 7866 1810 | | Client Services in US: | New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139 | | Client Services in Asia Pacific: | Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61 (2) 9293 2864 Japan + 81 (3) 3581 2764 |
Alternatively please visit our website at www.ftse.com |
